Out-licensing
We develop niche Rx molecules addressing low market availability, difficult licensing or market shortages.
Rx molecules
All products are developed and manufactured in the European Union, following EU guidelines. Each molecule is designed for stability in climatic zones II, IVa, and IVb.
Stability II, IVa, IVb
Stability testing ensures pharmaceuticals remain safe, effective, and meet regulatory standards across different environmental conditions that may be encountered during distribution and storage.
Partner with us
We are proud to announce the successful launch of our niche RX molecule business in multiple EU countries, advancing healthcare solutions. We invite prospective partners to join us in bringing cutting-edge solutions to patients around the world.
Featured products
